Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
Table 2
Comparison of patients with reversed septal curvature and nonreversed septal curvature.
RSC ()
Non-RSC ()
value
hs-TnI (ng/l)
102 (29.2-214.7)
8.7 (5.3-18)
0.001
NT-proBNP (pg/ml)
1279 (367.3-1186)
551.7 (273-969)
0.056
NT-proBNP/ULN
0.14
LVOTG at rest (mmHg)
10 (6.47-52)
8.2 (5.4-21)
0.3
LVOTG provocable (mmHg)
51 (9.5-105)
13.6 (7.5-31)
0.04
STD (mm)
0.02
LVEDD (mm)
0.001
STD/
14/17 (82%)
9/39 (18%)
0.001
EF (%)
0.7
Systolic pulmonary artery pressure (mmHg)
0.3
nsVT
11/17 (65.7%)
13/39 (33.3%)
0.02
Syncope
11/17 (65%)
12/39 (31%)
0.02
Family history of SCD
10/17 (59%)
12/39 (31%)
0.04
Risk of SCD at 5 years (%)
8.83 (4.37-12.35)
3.09 (1.9-4.76)
0.002
Data are presented as the mean and standard deviation or median and interquartile range. EF: ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVOTG: left ventricular outflow tract gradient; nsVT: nonsustained ventricular tachycardia; SCD: sudden cardiac death; STD: septal thickness at end diastole.